Facile anchoring mussel adhesive mimic tentacles on biodegradable polymer cargo carriers via self-assembly for microplastic-free cosmetics.

Enhancing the deposition of fragrance delivery systems contained in personal care products on target surfaces is crucial for increasing the longevity of scent, efficiently utilizing expensive functional compounds and limiting the generation of microplastics in domestic waste water. In this work, we designed and synthesized a new type of biomimetic macromolecules, chitosan-graft-L-lysine-L-DOPA (C-L-D), as a versatile biodegradable adhesion promoter to facilitate the deposition of biodegradable fragrance carriers on diverse surfaces including hair, cotton and skin. The C-L-D has hyperbranched chain architecture with many oligopeptide adhesive tentacles, each being a simple mimic of mussel adhesive proteins. It also exhibits unique amphiphilic characteristic. As a result, it could be facilely anchored on cargo-loaded poly(lactic-co-glycolic acid) nanoparticle surface via self-assembly in the particle preparation process. The C-L-D-modified nanoparticles show significantly higher deposition efficiencies than polyvinyl alcohol- and chitosan-coated particles when deposited on the target surfaces in different aqueous media as the lysine and DOPA units are capable of providing multi-noncovalent interactions, including electrostatic, polar, hydrophobic interactions, and bidentate hydrogen bonds, with the target surfaces, and possibly also inducing oxidative cross-linking. A much higher retention rate of the C-L-D-modified nanoparticles on cotton surface is also observed after washing with a soap solution, which could be attributed to the significant role played by bidentate hydrogen bonds. These findings suggest that C-L-D is a versatile biodegradable adhesion promoter and has the potential to be applied for various personal care applications and beyond.

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2

Sotrovimab (VIR-7831) and VIR-7832 are dual action monoclonal antibodies (mAbs) targeting the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Sotrovimab and VIR-7832 were derived from a parent antibody (S309) isolated from memory B cells of a 2003 severe acute respiratory syndrome coronavirus (SARS-CoV) survivor. Both mAbs contain an "LS" mutation in the Fc region to prolong serum half-life. In addition, VIR-7832 encodes an Fc GAALIE mutation that has been shown previously to evoke CD8+ T-cells in the context of an in vivo viral respiratory infection. Sotrovimab and VIR-7832 neutralize wild-type and variant pseudotyped viruses and authentic virus in vitro. In addition, they retain activity against monoclonal antibody resistance mutations conferring reduced susceptibility to previously authorized mAbs. The sotrovimab/VIR-7832 epitope continues to be highly conserved among circulating sequences consistent with the high barrier to resistance observed in vitro. Furthermore, both mAbs can recruit effector mechanisms in vitro that may contribute to clinical efficacy via elimination of infected host cells. In vitro studies with these mAbs demonstrated no enhancement of infection. In a Syrian Golden hamster proof-of concept wildtype SARS-CoV-2 infection model, animals treated with sotrovimab had less weight loss, and significantly decreased total viral load and infectious virus levels in the lung compared to a control mAb. Taken together, these data indicate that sotrovimab and VIR-7832 are key agents in the fight against COVID-19.

Highly Stable and Rapid Switching Electrochromic Thin Films Based on Metal-Organic Frameworks with Redox-Active Triphenylamine Ligands.

Metal-organic frameworks (MOFs), known for their tailorable porous structures and large specific surface areas, are appealing for electrochromic applications as their abundant pores may greatly benefit the charge transport required for electrochromic switching. Herein, for the first time, a simple, scalable, and cost-effective electrochemical deposition method for fabrication of high-performance and durable MOFs-based electrochromic films with redox-active ligands was developed. The fabricated film can achieve rapid switching speed (both coloration and bleaching time <5 s) because the inherent cavities of the MOFs greatly facilitate ion insertion and extraction. In addition, the film constructed with optimized parameters shows a high optical contrast of 65%@700 nm and can be stably switched for 1000 cycles with <5% contrast attenuation, which is by far the best cycling performance for MOFs-based electrochromic materials ever reported. Furthermore, our method enables the scalable preparation of large-area MOFs-based electrochromic thin films without using large high-pressure reaction vessels, and the as-prepared film in this work could be switched well between colored and bleached states. This new method, therefore, opens up a new avenue to broaden the use of MOFs-based thin films for electrochromic applications.